background: Embryologists currently face a challenge when counselling patients regarding the stage and the number of embryos to transfer when no top-quality embryos (TQE) are available.
Introduction
The main goal of IVF is the birth of a single healthy child, while twin or higher-order pregnancies must be regarded as complications (ESHRE Campus Course Report, 2001 ). The most effective way to minimize multiple pregnancies is to transfer a single embryo in a much greater proportion of IVF treatment cycles (Bergh, 2005) . However, reducing the number of embryos transferred without compromising a patient's chance of achieving a safe delivery is a considerable challenge (Land and Evers, 2003) . Moreover, some couples may be hesitant to proceed with a single embryo transfer (SET) because of their perception of reduced chances of success and because in many countries, the majority of patients undergoing IVF must meet most of the cost of assisted reproduction technology.
Selecting a cleavage-stage embryo with the highest implantation potential is a difficult task for embryologists. As there is evidence that top-quality embryos (TQE) have a higher chance of implantation compared with medium-, fair-or poor-quality embryos, it is usual to increase the number of embryos to be transferred when no TQE are available in an entire cohort on Day 2/3. This strategy has several shortcomings, resulting in failure of implantation for some couples and leading to multiple implantations in other embryo transfer attempts. Studies have shown that the predictive power of usual Day 2-3 morphological parameters has remained low (Rijnders and Jansen, 1998; Graham et al., 2000; Milki et al., 2002; Guerif et al., 2007) .
Recent advances in human IVF have been the result of the development of sequential media designed to promote embryo growth through Day 5/6 of development. Certain studies comparing elective SETs (eSETs) with single blastocyst transfers (SBTs) have shown significantly higher implantation rates after SBT compared with eSET (Papanikolaou et al., 2006; Zech et al., 2007; Guerif et al., 2009a) . By contrast, one potential drawback to the use of extended embryo culture is that some (or even all) embryos are unable to reach the blastocyst stage in culture, leading to increased risk of cancelled transfers (Jones et al., 1998; Tsirigotis, 1998) . It has therefore been suggested that there is a need to identify patients who would benefit from extended culture to Day 5/6. Reports based on selected populations of patients at greater risk of high-order multiple gestations showed that patients with at least two (Levitas et al., 2004) , three (Milki et al., 2000; Racowsky et al., 2000) , four (Papanikolaou et al., 2005) or five (Styer et al., 2008; Thum et al., 2010 ) TQE on Day 3 should be offered SBT; however, this research leaves unanswered the question of patients with no TQE available on Day 2 or Day 3. It has been reported that transfer of blastocysts is feasible for patients who have only fair-or poor-quality embryos on Day 3, leading to higher implantation rates compared with transfer of fair/ poor-quality embryos on Day 3 (Balaban et al., 2001) . However, the mean number of cleavage-stage embryos/blastocysts transferred in this study was ≥2. We recently showed that SBT might be a worthwhile strategy in women under 36 years, irrespective of embryo quality on Day 2, providing good delivery rates while keeping the rate of multiple deliveries low (Guerif et al., 2009b) . However, in our preliminary study, there was no control group including embryo transfers on Day 2.
To the best of our knowledge, the efficacy of SBT in women .36 years when no TQE is available on Day 2 compared with the transfer of two cleavage-stage embryos on Day 2 has never been assessed. A prospective study was undertaken to answer this question and the main outcomes were delivery rate, multiple delivery rate and clinical implantation rate in such a comparison.
Materials and Methods

Study design
A prospective study was undertaken at the IVF unit, Bretonneau University Hospital, Tours, France, between January 2007 and July 2009. The inclusion criteria were the following: (i) couples attempting first or second IVF, (ii) women under 36 years and (iii) couples without TQE on Day 2.
All couples were clearly informed by a physician regarding the risks of multiple pregnancies following the transfer of two day-2 embryos. Moreover, theoretical drawbacks (uncertainty of reaching the blastocyst stage) and advantages (embryo selection after genome activation, more accurate synchrony between blastocyst and endometrium, and lower uterine contraction at the time of blastocyst transfer) of extended culture were explained. The decision to schedule the transfer of two cleavage-stage embryos on Day 2 (DET group, n ¼ 225) or the transfer of a single blastocyst on Day 5/6 (SBT group, n ¼ 225) for couples without TQE on Day 2 was taken by the physician and the couple together. Written, informed consent was obtained from each couple. Couples were included only once in the study, and thus the number of cycles studied was equal to the number of patients enrolled.
Approval by the Institutional Review Board was not necessary because it is current practice in our IVF centre to transfer one blastocyst or two cleavage-stage embryos for couples attempting first or second IVF, independently of embryo quality on Day 2.
The main outcome was the clinical outcome, including delivery and multiple delivery rates in relation to the type of transfer.
IVF procedure
The ovarian stimulation protocol and the IVF and ICSI procedures used have already been described elsewhere (Guerif et al., 2004 
Morphological assessment of embryos
All the subsequent optical assessments were performed using an inverted microscope with Hoffman modulation contrast (×200 and ×400 magnification). All observations were performed by two experienced embryologists.
Embryos were evaluated 44-46 h post-insemination/ICSI (Day 2) on the basis of the number of blastomeres, shape (regularity) of cells, fragmentation rate and the presence of multinucleated blastomeres. Points were awarded for each early morphological aspect, taking into account all these findings, thus providing a simplified cumulative embryo score. The number of points given for each parameter studied was weighted according to previous findings (Guerif et al., 2007) . Briefly, 4-cell embryos were given 2 points, 5-or 6-cell embryos 1 point, and 2-or 3-cell embryos 0 points. Embryos with regular and even numbers of blastomeres were given two points, as were embryos with irregular and uneven numbers of blastomeres. Only one point was given to other embryos. Embryos with ,20% fragmentation were assigned two points, one point to embryos with 20 -50% fragmentation and zero when the fragmentation rate was over 50%. The final embryo score was then calculated by adding up points for the different features. Embryos with one or more multinucleated blastomeres were excluded from transfer and further extended embryo culture. A TQE with four regular blastomeres, ,20% fragmentation and no multinucleated blastomeres would thus have scored six points. In the design of the present study, no couple included had a TQE in the entire embryo cohort on Day 2. Embryo scores thus ranged from 1 to 5, and a mean embryo score was established on Day 2 for the entire cohort for each couple. Embryo cohorts were grouped into three classes: Poor embryo score when the mean score of the embryo cohort was ,3, medium embryo score when the mean score of the embryo cohort was ≥3 but ,4 and good embryo score when the mean score of the embryo cohort was ≥4 but ≤5.
Assessment of blastocyst morphology
The outcome of extended embryo culture was recorded for each individually cultured embryo. The morphological assessment was based on the expansion of the blastocoele cavity (B1 -B6) and the number and cohesiveness of the inner cell mass (ICM) and trophectodermal cells (Gardner and Schoolcraft, 1999 ).
In the study period, 225 IVF/ICSI cycles were programmed for SBT and when possible, a full (B3) or advanced (B4 -B6) blastocyst was selected for transfer on Day 5. If none of the embryos fulfilled these criteria, one early blastocyst (B1-B2) was transferred. When no blastocyst was available on Day 5, the transfer was postponed until Day 6. On Day 6, blastocyst transfer was carried out according to the same criteria described earlier. When no embryo was available that had reached at least the early blastocyst stage (B1) on Day 6, the transfer was cancelled.
In both the DET and SBT groups, only supernumerary blastocysts at the B2-B6 stages on Day 5 or the B3-B6 stages on Day 6 with an A/B ICM and A/B trophectoderm were frozen according to the cryopreservation procedures that have already been described (Guerif et al., 2004) .
Clinical outcome
The luteal phase was supported by 400 mg of vaginally administered micronized natural progesterone (Utrogestan w , Besins Iscovesco, Paris, France). Serum hCG levels were measured 10 days after Day 2 embryo transfer and 7 days after blastocyst transfer. Clinical pregnancy was defined as the presence of a gestational sac with fetal heart activity on ultrasound examination 5 weeks after oocyte retrieval. The implantation rate was defined as the number of gestational sacs divided by the number of embryos/blastocyst transferred.
Statistical analysis
Statistical analysis was performed using Statview 4.1 software (Abacus Concepts, Berkeley, CA, USA). Quantitative variables were compared using variance analysis followed by Fisher's PLSD test. Qualitative data were compared using contingency tables (x 2 test). Differences were considered significant when P , 0.05.
Results
A total of 450 women under 36 years who had no TQE available on Day 2 and were attempting first or second IVF were assigned to the transfer of either the DET group (two cleavage-stage embryos on Day 2, n ¼ 225) or the SBT group (a single blastocyst transferred on Day 5/6, n ¼ 225). Each couple was included once in the study. The diagnosis of infertility was similar between both studied groups. In the DET group, the diagnosis of infertility was the following: 31% (71/225) of female infertility, 13% (29/225) of male infertility, 52% (117/225) of mixed infertility and 4% (8/225) of unexplained infertility. In SBT group, the diagnosis of infertility was the following: 28% (63/225) of female infertility, 11% (25/225) of male infertility, 57% (128/225) of mixed infertility and 4% (9/225) of unexplained infertility. Detailed causes of infertility for both sexes are shown in Table I .
There was no difference between groups in terms of patient characteristics except that the men in the SBT group were older than those in the DET group (Table I ). The total number of oocytes retrieved, number of mature oocytes and fertilization rates did not differ between the groups and both the number of embryos and the embryo quality of the cohort based on mean embryo score on Day 2 were similar between groups (Table II) . There was no embryo cryopreservation on Day 2 in either group because only TQE are frozen on Day 2 in our IVF centre. As all the embryos from the whole cohort were placed in extended culture in SBT group, the rate of blastocyst development and the number of blastocysts developed were significantly higher in this group compared with the DET group (Table II) . When all cycles were considered, blastocyst cryopreservation was twice higher in the SBT group compared with the DET group (39 versus 18%, respectively), whereas the rates were similar when only cycles with extended culture were considered (39 versus 37%, respectively). When cryopreservation was possible, the number of blastocysts frozen was similar between groups.
The clinical outcome of the two groups is shown in Table III . The rate of transfer was significantly lower when all the embryos were cultured until Day 5/6 (88% in SBT group versus 100% in DET group, P , 0.0001). In SBT group, blastocyst transfer was mainly performed on Day 5 (77%) rather than Day 6 (23%). The rate of delivery per transfer was significantly higher when the transfer was performed on Day 5 compared with Day 6 (34.4 versus 15.6%, P , 0.05). The two monozygotic twins (MZT) recorded in the SBT group came from a transfer on Day 5. Moreover, the embryo score on Day 2 was significantly higher when the blastocyst transfer was performed on Day 5 (3.8 + 0.6 (Day 5) versus 3.5 + 0.7 (Day 6), P , 0.01).
Due to similarities in clinical pregnancy, miscarriage and ectopic pregnancy rates, the rate of delivery per oocyte retrieval was similar between the two groups (26.7% in DET and SBT groups). By contrast, the multiple delivery rate was 7-fold higher in the DET group compared with the SBT group (23.3 versus 3.3%, respectively, P , 0.01). No babies born after extended culture had congenital malformation at birth. The two MZT described in the SBT group resulted from ICSI. One MZT was obtained after the transfer of a blastocyst with 'good' morphological characteristics (Day 5, B4, with trophectoderm noted B and ICM noted A), whereas one MZT was obtained after the transfer of a blastocyst with 'poor' morphological characteristics (Day 5, B4, with trophectoderm noted C and ICM noted C). Moreover, because the number of embryos transferred was twice as high in the DET group than in the SBT group, the clinical implantation rate in the DET group was half that in the SBT group (18.2 versus 38.4%, respectively, P , 0.0001). The influence of overall embryo quality on Day 2 on the clinical outcome is summarized in Table IV . The DET and SBT groups were divided into subgroups according to the mean embryo score of the whole cohort. In the DET subgroups, clinical pregnancy, delivery and clinical implantation rates increased with the mean embryo score of the whole cohort, with the clinical implantation rate ranging from 7.8 to 25.9%. The multiple delivery rate was high (≥20%) when the mean embryo score was ≥3. The rate of transfer in the SBT subgroups increased with the mean embryo score of the cohort, ranging from 79 to 93%. However, clinical pregnancy, delivery and implantation rates in the SBT group were similar irrespective of the mean embryo score, with the clinical implantation rate ranging from 34.9 to 40.9%. Multiple deliveries in the SBT group were observed, 6.5% (MZT only) when the embryo score was ≥4. When similar SBT and DET subgroups were considered the clinical implantation rate was significantly higher in all SBT subgroups compared with the DET subgroups.
Discussion
This prospective study showed that extended culture may be offered to women .36 years for a first or a second IVF attempt when no TQE are available on Day 2. In such a situation, SBT achieves similar delivery rates to DET with the lowest possible risk of multiple pregnancies. Couples assigned to DET or SBT had similar clinical/biological and cycle characteristics, supporting the absence of any selection bias in the two groups.
For each individual couple, clinicians and embryologists face a difficult challenge when counselling patients concerning the number of embryos to transfer, trying to obtain the highest probability of achieving a live birth while keeping the risk of a multiple pregnancy as low as possible. There appears to be no general consensus between centres on the ideal selection criteria for patient selection for blastocyst transfers. Selected couples (young women, first cycle of IVF, good-quality embryos defined according to morphological criteria, excess embryos of sufficient quality to warrant cryopreservation, high number of oocytes, total embryos and TQE with the possibility of cryopreserving supernumerary embryos) are at increased risk of a multiple pregnancy (Practice Committees of ASRM and SART, 2009 ). For such couples with a more favourable prognosis, it is quite easy to propose a SET on Day 2/3 or on Day 5/6. Most studies reporting data with SBT include couples with 'good' prognosis [women under 37 years old and number of total embryos ≥7 (Ryan et al., 2007) ], number of TQE ≥5 (Styer et al., 2008) and number of blastocysts ≥3 (Criniti et al., 2005; Henman et al., 2005) . In such conditions, the rate of blastocyst development is high (.65%), the rate of transfer reaches 100% and the clinical pregnancy rate ranges from 48 to 76%. These data are very satisfying but remain restricted to a highly selected group of women with good prognosis. However, despite the benefits and apparent efficacy of SET with an appropriate subset of patients, the practice remains relatively uncommon [0.7% in Canada (Gunby and Daya, 2005) and 9% in the USA (Practice Committees of SART and ASRM, 2006) ] probably due to the fact that in most IVF centres, couples with good prognosis do not represent the majority of couples treated. As a consequence, despite a welcome trend towards reducing high-order multiple gestations by SBT by identifying selected patients with good prognosis according to guidelines for embryo transfer, the frequency of twin gestations remains at the constant rate of 25-40% in the USA (Dickey, 2007; Stern et al., 2007) . The overall rate of multiple pregnancies will significantly decrease only when the number of targeted couples increases. It therefore seems crucial to establish whether less strict criteria could be applied to determine whether or not a couple should be assigned to SBT. However, it is expected that the use of SET for unselected patients would reduce pregnancy rates substantially, which many practitioners and patients may consider unacceptable (Van Montfoort et al., 2006) . Few studies have investigated the application of this policy for couples with less favourable prognosis. A high rate of clinical pregnancy (66%) following SBT for women .38 years with at least three TQE has been reported (Mullin et al., 2010) . In this novel study, we have investigated the influence of embryo quality at Day 2 on the efficacy of SBT strategies in women under 36 attempting first or second IVF and without TQE. Our results (56% of blastocyst development, 88% of cycles with transfer and 33% of clinical pregnancy per oocyte retrieval) appear promising. In our study, only 12% of transfers were cancelled when no TQE were available on Day 2. In France, national policy allows for four fully subsidized IVF attempts with embryo transfer. When an IVF attempt does not result in a transfer, couples are allowed to undertake another IVF free of charge. Under such circumstances, couples are more easily convinced into accepting extended embryo culture to optimize their chances of initiating a pregnancy.
Regarding to the day of blastocyst transfer, we confirmed previous findings showing that the clinical outcome was better when a transfer was performed on Day 5 instead of Day 6 (Khorram et al., 2000; Shapiro et al., 2001 , Barrenetxea et al., 2005 . Higher implantation rates suggest a higher viability for faster developing embryos. However, an alternative explanation could be that embryos that have not developed to the blastocyst stage on Day 6 are more likely to miss the short window of endometrial receptivity (Diedrich et al., 2007) . In this case, considering the asynchrony between embryonic development and endometrial differentiation for a Day 6 blastocyst transfer, a frozen embryo transfer might be more suitable for a developmentally retarded Day 6 blastocyst. Although preventing dizygotic twinning, elective transfer on Day 5/6 does not preclude MZT. It has been shown that the incidence of monochorionic pregnancies associated with ART was 3.2%, eight times the background rate (Wenstrom et al., 1993) . Our findings (3.3%) confirm these data. There is considerable debate regarding the factors contributing to MZT as well as the mechanisms involved: maternal age, ovarian stimulation, ICSI, assisted hatching and blastocyst transfer. However, a recent study showed that MZT was not increased after SBT compared with single cleavage-stage embryo transfer (Papanikolaou et al., 2010) .
The majority of multiple pregnancies probably result from limitations in our ability to select the most competent embryos on Day 2/3 for transfer during IVF treatment. Embryos are routinely chosen from a cohort by morphological appearance and transferred on Day 2/3 at the 4-8-cell stage. Several studies have attempted to quantify the implantation potential of early embryos on the basis of different parameters such as cell number, cell size, cleavage speed and degree of fragmentation (Puissant et al., 1987; Steer et al., 1992; Fisch et al., 2001) , leading to the proposal of different embryo scoring systems (Giorgetti et al., 1995; Ziebe et al., 1997; Van Royen et al., 2001; Sjö blom et al., 2006; Holte et al., 2007) . In the DET group, some excess early embryos not available for cryopreservation on Day 2 reached the blastocyst stage, thus allowing cryopreservation. This is an important added value regarding the cumulative success rate, including fresh and frozen cycles. These findings indicate that embryo morphology and grading remain subject to interobserver and intraobserver variability (Bendus et al., 2006) . It is acknowledged that early morphological parameters alone or together provide only a limited guide to embryo viability (Rijnders and Jansen, 1998; De Placido et al., 2002; Milki et al., 2002; Guerif et al., 2007) . Couples eligible for this study had no TQE available on Day 2. This does not mean that all couples were poor prognosis couples. Non-TQE can be classified as good quality (e.g. embryos with four regular blastomeres and 20-50% fragmentation, embryos with four uneven blastomeres and ,20% fragmentation. Calculating the mean embryo score allowed us to distinguish between couples with really poor prognosis (mean embryo score below 3), medium prognosis (mean embryo score above 3 but under 4) and quite good prognosis (mean embryo score above 4). No multiple delivery was observed in the SBT or DET groups when the mean embryo score was low. When embryo quality was poor on Day 2 in the SBT group, the main difficulty was obtaining a blastocyst for transfer; however, this was achieved in 78% of cases. Once transfer has occurred, the women had similar chances of initiating a pregnancy as women with the highest mean embryo score. In all situations, the implantation rate was significantly higher in all SBT subgroups compared with the respective DET subgroups, irrespective of the mean embryo score.
In conclusion, this prospective study suggests that it is possible to lower the inclusion criteria for extended culture, with the aim of transferring a single blastocyst. Such an approach had a beneficial influence on the rate of multiple pregnancies without a deleterious effect on the rate of live births. Moreover, it highlights that in cases of poor embryo quality, extended culture takes advantage of blastocyst cryopreservation issued from embryos unavailable for early cryopreservation on Day 2. It seems that consideration should be given to lowering the threshold in order to offer extended embryo culture for women under 36 years attempting first or second IVF.
